BTIG analyst David Larsen maintained a Buy rating on Health Catalyst (HCAT – Research Report) on January 5 and set a price target of $15.00. The company’s shares closed last Friday at $9.54.
According to TipRanks, Larsen is an analyst with an average return of -9.6% and a 31.01% success rate. Larsen covers the Healthcare sector, focusing on stocks such as Apollo Medical Holdings, Health Catalyst, and LifeMD.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Health Catalyst with a $11.78 average price target, which is a 23.48% upside from current levels. In a report released on January 3, Evercore ISI also upgraded the stock to a Buy with a $11.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
The company has a one-year high of $15.87 and a one-year low of $6.60. Currently, Health Catalyst has an average volume of 526.2K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Health Catalyst (HCAT) Company Description:
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in Salt Lake City, UT.
Read More on HCAT:
- ‘Profitability Is the Key’: Barclays Says These 3 Health Tech Stocks Are Poised for Growth
- Health Catalyst upgraded to Outperform at Evercore ISI on IT demand inflection
- Barclays starts healthcare technology, distribution with Neutral view
- Health Catalyst upgraded to Outperform from In Line at Evercore ISI
- Health Catalyst initiated with an Overweight at Barclays
